Cleveland Biolabs Inc. Announces Appointment of International Expert in Chemical, Biological and Radiological/Nuclear Threat Countermeasures as Senior Vice President of Public Health and Government Services

BUFFALO, NY--(Marketwire - December 01, 2008) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the appointment of Michelle Ross, DVM, M.S, Ph.D., as Senior Vice President of Public Health and Government Services, with responsibility for commercialization of military and public health medical emergencies applications. Dr. Ross joins Cleveland BioLabs while remaining a Senior Partner for Biodefense and Public Health Programs with Martin, Blanck & Associates, a federal health services consulting firm.